Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Liabilities and Shareholders Equity (2016 - 2025)

Anterix's Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $417.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 27.65% year-over-year to $417.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 18.61%, while the annual FY2025 figure was $333.1 million, 2.53% up from the prior year.
  • Liabilities and Shareholders Equity reached $417.0 million in Q4 2025 per ATEX's latest filing, down from $420.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $420.4 million in Q3 2025 to a low of $248.1 million in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $304.0 million, with a median of $284.0 million recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 10.57% in 2022, then surged 32.51% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $288.1 million in 2021, then dropped by 10.57% to $257.6 million in 2022, then increased by 24.56% to $320.9 million in 2023, then rose by 1.81% to $326.7 million in 2024, then rose by 27.65% to $417.0 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Liabilities and Shareholders Equity are $417.0 million (Q4 2025), $420.4 million (Q3 2025), and $359.6 million (Q2 2025).